Therapeutic Potential of Anti-ErbB3 Chimeric Antigen Receptor Natural Killer Cells against Breast Cancer

Investigators reported the generation of ErbB3-targeted chimeric antigen receptor-modified natural killer (NK) cells by transducing cord blood-derived primary NK cells using vsv-g envelope-pseudotyped lentiviral vectors.